Archer Materials Limited (ASX:AXE) Enhances Biochip Feasibility and Advances Development Roadmap
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.

Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.
4DMedical (ASX:4DX) secures Canadian approval for CT LVAS™, expanding its respiratory imaging portfolio and market reach.
4DMedical Limited (ASX:4DX) launches a Share Purchase Plan, enabling shareholders to buy up to $30,000 in new shares without fees.
XPON Technologies Group (ASX:XPN) announces H1 FY25 results, highlighting operational achievements and improved financial performance.
AVA Risk Group Limited (ASX:AVA) reports a 20% revenue increase and significant EBITDA improvement in H1 FY2025, driven by its Detect segment.
Envirosuite (ASX:EVS) receives a non-binding proposal from Ideagen to acquire 100% of its shares at $0.10 per share.
Bigtincan Holdings Limited (ASX:BTH) reports a 15% revenue decline and a significant net loss for the half-year ended 31 December 2024.
Zip Co Limited (ASX:ZIP) reports a 117.1% increase in cash EBITDA for 1H FY25, driven by strong US growth and disciplined strategy execution.
Advanced Braking Technology Ltd (ASX:ABV) reports record H1 FY25 revenue and a 234% increase in net profit, alongside the launch of BrakeIQ.
Aerometrex Limited (ASX:AMX) initiates a strategic review to optimise costs and unlock value across its MetroMap, LiDAR, and 3D divisions.